• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

First-Time Generics - March 2010

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 TEMOZOLOMIDE CAPSULES, 5 MG, 20 MG, 100 MG, 140 MG, 180 MG AND 250 MG   BARR LABORATORIES, INC. TEMODAR CAPSULES 3/1/2010
2 TAMSULOSIN HYDROCHLORIDE CAPSULES USP, 0.4 MG IMPAX LABORATORIES, INC. FLOMAX CAPSULES 3/2/2010
3 DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP, 120 MG, 180 MG, 240 MG, 300 MG, 360 MG AND 420 MG (ONCE A DAY DOSAGE) WATSON LABORATORIES, INC. - FLORIDA CARDIZEM LA EXTENDED-RELEASE TABLETS 3/15/2010
4 DACTINOMYCIN FOR INJECTION USP, 0.5 MG/VIAL    BEDFORD LABORATORIES COSMEGEN FOR INJECTION, 0.5 MG/VIAL 3/16/2010
5 FEXOFENADINE HCL & PSEUDOEPHEDRINE HCL EXTENDED-RELEASE TABL 180 MG/240 MG (24 HOUR DOSAGE)    DR. REDDY'S LABORATORIES, LIMITED ALLEGRA-D 24-HOUR EXTENDED-RELEASE TABLETS 3/17/2010
6 FLUOXETINE DELAYED-RELEASE CAPSULES USP, (ONCE WEEKLY) 90 MG    DR. REDDY'S LABORATORIES LIMITED PROZAC WEEKLY DELAYED-RELEASE CAPSULES 3/22/2010
7 CALCIPOTRIENE OINTMENT, 0.005%   GLENMARK GENERICS INC., USA DOVONEX OINTMENT 3/24/2010
8 CLINDAMYCIN PHOSPHATE FOAM, 1%        COBREK PHARMACEUTICALS, INC. EVOCLIN TOPICAL FOAM 3/31/2010
9 METAXALONE TABLETS, 800 MG SANDOZ INC. SKELAXIN TABLETS 3/31/2010